Behind the recent flurry of headlines about a massive surge in heroin use is a much more widespread wave of addiction to legal opioids—OxyContin, Vicodin and other painkillers.
One recent study found that 4 in 5 heroin users previously abused prescription opioids. In the last 15 years, at least 100,000 people have died from prescription opioid abuse.
Last fall, the Food and Drug Administration (FDA) approved a powerful, new painkiller called Zohydro, a pure form of hydrocodone that contains five to 10 times the opiate level of Vicodin. The FDA approved Zohydro even though its own advisory committee voted 11 to 2 against approval, citing the drug’s potential to exacerbate the opioid abuse epidemic.
Fault Lines examines the opioid epidemic in the U.S., and asks whether federal drug policy privileges Big Pharma’s bottom line over larger concerns of public health.
Original air date: October 25, 2014
Fault Lines examines America's profitable bail bond industry—and how money determines who stays behind bars
Fault Lines reports from the Taliban stronghold of Charkh District as it attacks an Afghan National Army base
Fault Lines reports from Charkh District where the Taliban patrols the streets and has built a parallel government.
We use cookies and other tracking technologies to deliver and personalize content and ads, enable features, measure site performance, and enable social media sharing. You can choose to customize your preferences.Learn more about our Cookie Policy.
These cookies are necessary for our website to function, and we can not switch them off in our systems. They provide you with essential services and features available through the websites that you have requested. Some parts of our website will not work if you set your browser to block these cookies. These cookies do not store any personally identifiable information.
These first party cookies are necessary and these allow us to understand how you interact with our websites. It helps us to make internal business decisions, like how we can best improve our site design, performance, or stability. We receive this information aggregated and anonymized.
These cookies allow us to understand how you interact with our websites. It helps us to make internal business decisions, like how we can best improve our site design, performance, or stability. We receive this information aggregated and anonymized.
These cookies enable the website to provide enhanced functionality and personalization. We or our providers whose services we have added to our pages set these cookies. If you do not allow these cookies, some or all of these services may not function properly.
These cookies may be set through our site by our advertising partners. Advertisers use this information to build a profile and make advertising messages more relevant to you. They do not store personal information directly but uses unique identifiers of your browser or device.
These cookies enable you to share or follow the content you find interesting. Our social media partners set these cookies through our websites. This allows us to provide seamless integration between our websites and the social media networks and tools you like.
Error
Sorry, your comment was not saved due to a technical problem. Please try again later or using a different browser.